Who We Are
We’re a bit of a rarity in the industry—an independent, family-owned CDMO with the commercial pedigree of 80 products brought to market and longstanding experience as a Big Pharma supplier.
ABOUT UPMWhat We Do
UPM manufactures semi-solid and solid dose drug product, with a particularly robust track record in late‑stage commercial production, including tech transfers and scale-up.
Annual Production Capabilities
3.5B
Tablets
680M
Capsules
1,300
Metric Tons of Semi-Solids
What We Handle
Over decades of experience, we have honed our expertise to specialize in the intricate processes involved in potent handling, hormones and DEA-licensed controlled substances. We also support commercial transfer projects in oral solid dose and semi-solids, involving up to hundreds of millions of doses annually.
Where It Happens
Owned and operated primarily by the same family business legacy for more than 25 years, our nearly 500,000 square-foot facility has seen over 80 compounds advanced from proof of concept to commercialization and continues to manufacture several commercialized products.
FACILITY OVERVIEWFacility At A Glance
475,000 ft2
Commercial Manufacturing Facility
250,000 ft2
Warehouse
15,800 ft2
DEA Approved Vault Space
7-Acre
Pharmaceutical Campus
What We're Talking About
Pharma's Almanac
Advancing Commercial Manufacturing from Orphan Drugs to Blockbusters